Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.60m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Director Dealing

25 Mar 2025 14:20

RNS Number : 1080C
Science Group PLC
25 March 2025
 

 

25 March 2025

 

Science Group plc

(the "Company" or "Science Group")

 

Director Dealing

 

Science Group plc (AIM:SAG) announces that it has been notified by Daniel Edwards, Group Managing Director of the Company that on 25 March 2025 he purchased 6,667 ordinary shares of 1p each in the Company at a price of 425 pence per share.

 

Following this purchase, Daniel Edwards has an interest in 100,000 ordinary shares in the Company (being approximately 0.22% of the issued share capital excluding treasury shares).

 

All other Directors' beneficial interests in the share capital of the Company remain unchanged and as previously announced. 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Daniel Edwards

2.

Reason for the notification

a)

Position/status: Group Managing Director

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Science Group plc

b)

LEI: 2138009OJQT79BDB3E93

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 1p each.

Identification code: GB00B39GTJ17

b)

Nature of the transaction: Purchase of shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

425p

6,667

d)

Aggregated information:

· Aggregated volume: 6,667

· Price: £28,334.75

e)

Date of the transaction: 2025-03-25

f)

Place of the transaction: AIMX

 

 

- Ends -

 

 

For further information:

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

www.sciencegroup.com  

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Simon Bridges, Andrew Potts

Tel: +44 (0) 20 7523 8000

Liberum Capital Limited (Joint Broker)

Max Jones, John More

Tel: +44 (0) 20 3100 2000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSELFLIEISEFD
Date   Source Headline
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20248:25 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSIssue of share options & PDMR dealing
21st Aug 20247:00 amRNSExecutive Chair Share Purchase
20th Aug 20247:00 amRNSExecutive Chair Share Purchase
19th Aug 20247:00 amRNSExecutive Chair Share Purchase
16th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSInterim results for six months ended 30 June 2024
18th Jul 202412:30 pmRNSNotice of Interim Results
1st Jul 20247:00 amRNSTotal Voting Rights
18th Jun 202411:40 amRNSResult of AGM
18th Jun 20247:00 amRNSAGM Trading Update
3rd Jun 20247:00 amRNSTotal Voting Rights
22nd May 20247:00 amRNSTreasury shares issued & PDMR dealing
21st May 20247:00 amRNSNotice of Annual General Meeting
2nd May 20247:00 amRNSIssue of share options & PDMR dealing
1st May 20247:00 amRNSTransaction in Own Shares & Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20249:12 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTreasury shares issued
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTreasury shares issued & PDMR dealing
8th Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSAudited results for year ended 31 December 2023
19th Mar 20247:00 amRNSNotice of Preliminary Results
26th Jan 20247:00 amRNSRule 19.6(c) confirmation of post-offer intentions
22nd Dec 20237:00 amRNSRule 19.6(b) update to post-offer intentions
18th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.